Cedars-Sinai Academic Affairs Administrative Office
8700 Beverly Blvd Rm 2015Los Angeles, CA 90048
The research focus of Dr. Shlomo Melmed is molecular pathogenesis of pituitary tumors and pituitary receptor signaling. He employs molecular, cellular, transgenic animal and human tissue models to understand the biology of these commonly encountered hormone-secreting adenomas. He tests pituitary receptor signaling to develop novel peptide analog treatments for these tumors secreting growth hormone… Read more ›
University | Degree | Focus | Graduated |
---|---|---|---|
University of Capetown | Doctorate | Other | 1970 |
Years In Practice: 48 (started in 1977)
Accepts New Patients: Yes
Shlomo Melmed, MB, ChB, FRCP, MACP has not yet listed the medications that he commonly prescribes.
Shlomo Melmed, MB, ChB, FRCP, MACP has not yet specified the insurance plans he accepts.